These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30887947)

  • 1. Approval of Tafenoquine for Malaria Chemoprophylaxis.
    Berman JD
    Am J Trop Med Hyg; 2019 Jun; 100(6):1301-1304. PubMed ID: 30887947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.
    Dow GS; McCarthy WF; Reid M; Smith B; Tang D; Shanks GD
    Malar J; 2014 Feb; 13():49. PubMed ID: 24502679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tafenoquine: the new kid on the block.
    Chen V; Daily JP
    Curr Opin Infect Dis; 2019 Oct; 32(5):407-412. PubMed ID: 31305490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tafenoquine and G6PD: a primer for clinicians.
    Chu CS; Freedman DO
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30941413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries.
    Dow GS; Liu J; Lin G; Hetzell B; Thieling S; McCarthy WF; Tang D; Smith B
    Malar J; 2015 Nov; 14():473. PubMed ID: 26610844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
    Hale BR; Owusu-Agyei S; Fryauff DJ; Koram KA; Adjuik M; Oduro AR; Prescott WR; Baird JK; Nkrumah F; Ritchie TL; Franke ED; Binka FN; Horton J; Hoffman SL
    Clin Infect Dis; 2003 Mar; 36(5):541-9. PubMed ID: 12594633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tafenoquine: a toxicity overview.
    Chu CS; Hwang J
    Expert Opin Drug Saf; 2021 Mar; 20(3):349-362. PubMed ID: 33306921
    [No Abstract]   [Full Text] [Related]  

  • 8. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
    N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (
    Rueangweerayut R; Bancone G; Harrell EJ; Beelen AP; Kongpatanakul S; Möhrle JJ; Rousell V; Mohamed K; Qureshi A; Narayan S; Yubon N; Miller A; Nosten FH; Luzzatto L; Duparc S; Kleim JP; Green JA
    Am J Trop Med Hyg; 2017 Sep; 97(3):702-711. PubMed ID: 28749773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria chemoprophylaxis with tafenoquine: a randomised study.
    Lell B; Faucher JF; Missinou MA; Borrmann S; Dangelmaier O; Horton J; Kremsner PG
    Lancet; 2000 Jun; 355(9220):2041-5. PubMed ID: 10885356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
    N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Schizonticidal Activity and Safety of Tafenoquine When Administered as Chemoprophylaxis to Healthy, Nonimmune Participants Followed by Blood Stage Plasmodium falciparum Challenge: A Randomized, Double-blind, Placebo-controlled Phase 1b Study.
    McCarthy JS; Smith B; Reid M; Berman J; Marquart L; Dobbin C; West L; Read LT; Dow GS
    Clin Infect Dis; 2019 Jul; 69(3):480-486. PubMed ID: 30388194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.
    Commons RJ; McCarthy JS; Price RN
    Med J Aust; 2020 Mar; 212(4):152-153.e1. PubMed ID: 32036613
    [No Abstract]   [Full Text] [Related]  

  • 14. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
    Shanks GD; Oloo AJ; Aleman GM; Ohrt C; Klotz FW; Braitman D; Horton J; Brueckner R
    Clin Infect Dis; 2001 Dec; 33(12):1968-74. PubMed ID: 11700577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tafenoquine for malaria chemoprophylaxis (1998-2020): A systematic review and meta-analysis.
    Maier JD; Siegfried S; Gültekin N; Stanga Z; Baird JK; Grobusch MP; Schlagenhauf P
    Travel Med Infect Dis; 2021; 39():101908. PubMed ID: 33227500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
    Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.
    Nasveld PE; Edstein MD; Reid M; Brennan L; Harris IE; Kitchener SJ; Leggat PA; Pickford P; Kerr C; Ohrt C; Prescott W;
    Antimicrob Agents Chemother; 2010 Feb; 54(2):792-8. PubMed ID: 19995933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.